Literature DB >> 11575066

Worry content reported by older adults with and without generalized anxiety disorder.

G J Diefenbach1, M A Stanley, J G Beck.   

Abstract

This study investigated worry content in older adults with and without generalized anxiety disorder (GAD). This is an important topic of research, where findings may promote improved recognition and treatment of this disorder in late-life, as well as provide information about the nature of worry across the lifespan. Worry content was compared for 44 older adults diagnosed with GAD and 44 normal control (NC) volunteers matched for age, gender, and ethnicity. Results indicated that older adults with GAD reported a wider variety of worry topics than did NC participants. However, there were no differences in worry content patterns between older adults with and without GAD. These results suggest that pathological worry in later life is not uniquely defined by content, and implications of these findings for assessment and treatment of GAD in older adults are discussed. Worry content reported by older adults also was compared with previously published younger adult worry content data. Age differences in worry content were found in both the clinical and non-clinical groups in patterns that were generally consistent with common age-related developmental changes. Directions for future research of worry across the lifespan are proposed.

Entities:  

Mesh:

Year:  2001        PMID: 11575066     DOI: 10.1080/13607860120065069

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  14 in total

1.  Characteristics of generalized anxiety disorder in patients with dementia.

Authors:  Jessica S Calleo; Mark E Kunik; Dana Reid; Cynthia Kraus-Schuman; Amber Paukert; Tziona Regev; Nancy Wilson; Nancy J Petersen; A Lynn Snow; Melinda Stanley
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-11-07       Impact factor: 2.035

2.  Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder.

Authors:  Meryl A Butters; Rishi K Bhalla; Carmen Andreescu; Julie Loebach Wetherell; Rose Mantella; Amy E Begley; Eric J Lenze
Journal:  Br J Psychiatry       Date:  2011-07-04       Impact factor: 9.319

3.  Do negative affect characteristics and subjective memory concerns increase risk for late life anxiety?

Authors:  Chelsey M Wilkes; Helen W Wilson; John L Woodard; John E Calamari
Journal:  J Anxiety Disord       Date:  2013-04-03

4.  Expression of Generalized Anxiety Disorder Across the Lifespan.

Authors:  Jeannette K Correa; Timothy A Brown
Journal:  J Psychopathol Behav Assess       Date:  2018-09-15

5.  Not to worry: Episodic retrieval impacts emotion regulation in older adults.

Authors:  Helen G Jing; Kevin P Madore; Daniel L Schacter
Journal:  Emotion       Date:  2019-02-28

6.  Altered cerebral blood flow patterns associated with pathologic worry in the elderly.

Authors:  Carmen Andreescu; James J Gross; Eric Lenze; Kathryn Dunfee Edelman; Sara Snyder; Costin Tanase; Howard Aizenstein
Journal:  Depress Anxiety       Date:  2011-03       Impact factor: 6.505

7.  Attentional bias for threat in older adults: moderation of the positivity bias by trait anxiety and stimulus modality.

Authors:  Lewina O Lee; Bob G Knight
Journal:  Psychol Aging       Date:  2009-09

8.  Associations of physical activity with anxiety symptoms and status: results from The Irish longitudinal study on ageing.

Authors:  C P McDowell; B R Gordon; K L Andrews; C MacDonncha; M P Herring
Journal:  Epidemiol Psychiatr Sci       Date:  2018-01-31       Impact factor: 6.892

9.  Age and racial differences in the presentation and treatment of Generalized Anxiety Disorder in primary care.

Authors:  Gretchen A Brenes; Mark Knudson; W Vaughn McCall; Jeff D Williamson; Michael E Miller; Melinda A Stanley
Journal:  J Anxiety Disord       Date:  2007-12-03

Review 10.  Cognitive aspects of anxiety and depression in the elderly.

Authors:  J Gayle Beck
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 8.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.